Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: Higher payments for CCTA | Lessons from EARLY TAVR | FDA approves another PFA system
Saturday, November 9, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

READ MORE >
patient undergoing CCTA exam
Share on Twitter Share on Facebook Share on Linkedin

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

Share on Twitter Share on Facebook Share on Linkedin
patient undergoing CCTA exam
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
READ MORE >

CMS makes 2025 Medicare cuts official—and doctors are not happy

CMS has published its final rule for the 2025 Medicare Physician Fee Schedule, and it includes significant payment cuts. Cardiology groups have been working hard to stop these changes from going into effect since they were first proposed in July.

READ MORE >
Medicare money payment reimbursement dollar decline. More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 
Share on Twitter Share on Facebook Share on Linkedin

CMS makes 2025 Medicare cuts official—and doctors are not happy

Share on Twitter Share on Facebook Share on Linkedin
Medicare money payment reimbursement dollar decline. More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 
CMS has published its final rule for the 2025 Medicare Physician Fee Schedule, and it includes significant payment cuts. Cardiology groups have been working hard to stop these changes from going into effect since they were first proposed in July.
READ MORE >

New Orleans cardiologist accused of sexually assaulting patients

The 63-year-old doctor was arrested on charges of sexual battery, battery and simple assault on Oct. 30. 

READ MORE >
offender-trouble-handcuffs-police-arrest-2102488.jpg
Share on Twitter Share on Facebook Share on Linkedin

New Orleans cardiologist accused of sexually assaulting patients

Share on Twitter Share on Facebook Share on Linkedin
offender-trouble-handcuffs-police-arrest-2102488.jpg
The 63-year-old doctor was arrested on charges of sexual battery, battery and simple assault on Oct. 30. 
READ MORE >

Robotic aortic valve replacement may offer certain benefits over TAVR

Robotic-assisted aortic valve surgery may be a safe, effective alternative to TAVR when treating low- and intermediate-risk patients. A new analysis in The Annals of Thoracic Surgery explored this topic at length.

READ MORE >
A Da Vinci Xi robot from California-based Intuitive Surgical. Researchers used these robotic surgical systems to help guide AVR in low- and intermediate-risk patients who presented with severe AS.
Share on Twitter Share on Facebook Share on Linkedin

Robotic aortic valve replacement may offer certain benefits over TAVR

Share on Twitter Share on Facebook Share on Linkedin
A Da Vinci Xi robot from California-based Intuitive Surgical. Researchers used these robotic surgical systems to help guide AVR in low- and intermediate-risk patients who presented with severe AS.
Robotic-assisted aortic valve surgery may be a safe, effective alternative to TAVR when treating low- and intermediate-risk patients. A new analysis in The Annals of Thoracic Surgery explored this topic at length.
READ MORE >

Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes

Philippe Genereux, MD, principal investigator of the EARLY TAVR trial, discussed how a proactive treatment strategy for patients with asymptomatic AS can lead to better outcomes and improvements in quality of life.

READ MORE >
Philippe Genereux, MD, explains the details of the EARLY TAVR trial, which compared early interventions vs. waiting in patients with asymptomatic severe aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes

Share on Twitter Share on Facebook Share on Linkedin
Philippe Genereux, MD, explains the details of the EARLY TAVR trial, which compared early interventions vs. waiting in patients with asymptomatic severe aortic stenosis.
Philippe Genereux, MD, principal investigator of the EARLY TAVR trial, discussed how a proactive treatment strategy for patients with asymptomatic AS can lead to better outcomes and improvements in quality of life.
READ MORE >

Cardiologist loses medical license over years-long fraud scheme

The New Jersey doctor already admitted to collecting more than $1.9 million in false claims from 2017 to 2022. He is also under investigation for an unrelated charge of fourth-degree criminal sexual contact due to an alleged incident with a patient.

READ MORE >
healthcare insurance fraud scam scheme legal lawsuit
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist loses medical license over years-long fraud scheme

Share on Twitter Share on Facebook Share on Linkedin
healthcare insurance fraud scam scheme legal lawsuit
The New Jersey doctor already admitted to collecting more than $1.9 million in false claims from 2017 to 2022. He is also under investigation for an unrelated charge of fourth-degree criminal sexual contact due to an alleged incident with a patient.
READ MORE >

American Heart Association announces late-breaking research for Scientific Sessions 2024

The three-day conference begins Saturday, Nov. 16, in Chicago. Topics will include AI, heart failure, patient management and much more. 

READ MORE >
The entrance to the AHA expo and technology floor. Photo by Dave Fornell #AHA22
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association announces late-breaking research for Scientific Sessions 2024

Share on Twitter Share on Facebook Share on Linkedin
The entrance to the AHA expo and technology floor. Photo by Dave Fornell #AHA22
The three-day conference begins Saturday, Nov. 16, in Chicago. Topics will include AI, heart failure, patient management and much more. 
READ MORE >

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

READ MORE >
HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI tool that flags signs of heart disease in chest CT scans

Share on Twitter Share on Facebook Share on Linkedin
HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 
READ MORE >

Cardiologist explores why colchicine failed to help heart attack patients

Sanjit S. Jolly, MD, MSc, reviewed his team's late-breaking data on treating heart attack patients with colchicine. "I think inflammation is an important area, but I don't think colchicine is the magic bullet," he said.

READ MORE >
Sanjit Jolly, MD, says cholchicine failed to help heart attack patients in the CLEAR SYNERGY (OASIS 9) presented as a TCT 2024 late-breaker.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist explores why colchicine failed to help heart attack patients

Share on Twitter Share on Facebook Share on Linkedin
Sanjit Jolly, MD, says cholchicine failed to help heart attack patients in the CLEAR SYNERGY (OASIS 9) presented as a TCT 2024 late-breaker.
Sanjit S. Jolly, MD, MSc, reviewed his team's late-breaking data on treating heart attack patients with colchicine. "I think inflammation is an important area, but I don't think colchicine is the magic bullet," he said.
READ MORE >

Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system

Johnson & Johnson is now the third company with an FDA-approved PFA system in its portfolio, joining Medtronic and Boston Scientific. Varipulse previously gained CE mark approval in February. 

READ MORE >
The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system

Share on Twitter Share on Facebook Share on Linkedin
The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA
Johnson & Johnson is now the third company with an FDA-approved PFA system in its portfolio, joining Medtronic and Boston Scientific. Varipulse previously gained CE mark approval in February. 
READ MORE >

Renal denervation systems from Recor Medical, Medtronic receive new outpatient payments

Both FDA-approved systems previously received inpatient payments in August. 

READ MORE >
The Recor Medical renal denervation (RDN) system, pictured here at TCT 2024, and Medtronic’s Symplicity Spyral RDN system have received transitional pass-through payments from CMS for 2025.
Share on Twitter Share on Facebook Share on Linkedin

Renal denervation systems from Recor Medical, Medtronic receive new outpatient payments

Share on Twitter Share on Facebook Share on Linkedin
The Recor Medical renal denervation (RDN) system, pictured here at TCT 2024, and Medtronic’s Symplicity Spyral RDN system have received transitional pass-through payments from CMS for 2025.
Both FDA-approved systems previously received inpatient payments in August. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup